A potential coronavirus vaccine developed by U.S. biotech company Moderna and the National Institutes of Health started its final phase of testing Monday. The trial includes up to 30,000 volunteers.
Coronavirus Vaccine Developed In The U.S. Moves To Final Testing Phase
